Gene · 5452
Papers3,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Diagnostic Dilemma and Classification Conundrum: Atypical Histiocytic Neoplasm Presenting as a Calvarial Mass. | Cureus | 2024 | 38529420 | PubTator, text mining | PubMed |
| Evaluation of OCT2-mediated drug-drug interactions between ulotaront and metformin in subjects with schizophrenia. | Pharmacol Res Perspect | 2024 | 38527949 | PubTator, text mining | PubMed |
| Cellular senescence: Neither irreversible nor reversible. | J Exp Med | 2024 | 38385946 | PubTator, text mining | PubMed |
| Alkaloid uptake pathways in renal tubular epithelial cells from different processed products of Phellodendri chinensis Cortex. | J Pharm Biomed Anal | 2024 | 38367517 | PubTator, text mining | PubMed |
| Homeobox Protein BarH-like 1 Promotes Gastric Cancer Progression by Activating Coiled-Coil Domain-Containing Protein 178. | Dig Dis Sci | 2024 | 38358459 | PubTator, text mining | PubMed |
| Identification of a core transcriptional program driving the human renal mesenchymal-to-epithelial transition. | Dev Cell | 2024 | 38340720 | PubTator, text mining | PubMed |
| Primary anaplastic lymphoma kinase-positive large B-cell lymphoma of the left bulbar conjunctiva: A case report. | World J Clin Cases | 2024 | 38322452 | PubTator, text mining | PubMed |
| POU2F2-mediated upregulation of lncRNA PTPRG-AS1 inhibits ferroptosis in breast cancer via miR-376c-3p/SLC7A11 axis. | Epigenomics | 2024 | 38318853 | PubTator, text mining | PubMed |
| Immunoregulatory and neutrophil-like monocyte subsets with distinct single-cell transcriptomic signatures emerge following brain injury. | J Neuroinflammation | 2024 | 38310257 | PubTator, text mining | PubMed |
| IκBζ is a dual-use coactivator of NF-κB and POU transcription factors. | Mol Cell | 2024 | 38309274 | PubTator, text mining | PubMed |
| MiRNAs as potential therapeutic targets and biomarkers for non-traumatic intracerebral hemorrhage. | Biomark Res | 2024 | 38308370 | PubTator, text mining | PubMed |
| A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants. | J Pharmacol Exp Ther | 2024 | 38296646 | PubTator, text mining | PubMed |
| Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells. | Cancers (Basel) | 2024 | 38275910 | PubTator, text mining | PubMed |
| In Vitro Evaluation of Drug-Drug Interaction Potential of Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor. | Pharmaceuticals (Basel) | 2024 | 38256953 | PubTator, text mining | PubMed |
| Posttranslational Acylations of the Rat Brain Transketolase Discriminate the Enzyme Responses to Inhibitors of ThDP-Dependent Enzymes or Thiamine Transport. | Int J Mol Sci | 2024 | 38255994 | PubTator, text mining | PubMed |
| Transcriptional Coactivator BOB1 (OBF1, OCA-B) Modulates the Specificity of DNA Recognition by the POU-Domain Factors OCT1 and OCT2 in a Monomeric Configuration. | Biomolecules | 2024 | 38254723 | PubTator, text mining | PubMed |
| GC-MS analysis, molecular docking, and pharmacokinetic studies of Multidentia crassa extracts' compounds for analgesic and anti-inflammatory activities in dentistry. | Sci Rep | 2024 | 38253619 | PubTator, text mining | PubMed |
| Hypoxia-Inducible Factor and Oxidative Stress in Tendon Degeneration: A Molecular Perspective. | Antioxidants (Basel) | 2024 | 38247510 | PubTator, text mining | PubMed |
| Tumor-derived small extracellular vesicles in cancer invasion and metastasis: molecular mechanisms, and clinical significance. | Mol Cancer | 2024 | 38243280 | PubTator, text mining | PubMed |
| Characterization of the Immune Microenvironment and Identification of Biomarkers in Chronic Rhinosinusitis with Nasal Polyps Using Single-Cell RNA Sequencing and Transcriptome Analysis. | J Inflamm Res | 2024 | 38229690 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5452/papers?page=9